Answers are grounded in this paper and cite their sources.
Type 2 diabetes mellitus is characterized by progressive β-cell dysfunction and hepatic insulin resistance, yet the molecular mechanisms linking pancreatic stress to impaired hepatic glucose metabolism remain unclear. In this context, Xu et al recently published a study in World Journal of Diabetes that identified a previously unrecognized mode of pancreas-liver communication mediated by exosomal miR-375-3p. Under glucotoxicity conditions, pancreatic β cells release exosomes enriched with miR-375-3p that are taken up by hepatocytes, where they suppress recombination signal binding protein for immunoglobulin kappa J region expression, impair protein kinase B/glycogen synthase kinase signaling, and reduce hepatic glycogen storage. This mechanism extends the classical pancreas-liver axis beyond insulin signaling and highlights small RNA cargo as a regulator of glucose homeostasis. However, the relevance of this pathway in humans, its tissue specificity beyond the liver, and the potential of circulating exosomal miR-375-3p as an early biomarker of β-cell stress remain unclear. This editorial discusses the study’s strengths and limitations and outlines future directions for validating this axis as a diagnostic and therapeutic target in type 2 diabetes mellitus.
No takes yet. Share an insight, caveat, or question.
Thi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: